Comparison 2.
Fluoxetine vs Heterocyclics
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Failure to respond - HDRS (−50%) | 3 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Subtotals only | |
1.1 Fluoxetine vs Maprotiline | 2 | 163 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.92 [0.92, 3.98] |
1.2 Fluoxetine vs Mianserin | 1 | 53 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.81 [0.27, 2.36] |
2 End-point score on HDRS | 8 | Std. Mean Difference (IV, Random, 95% CI) | Subtotals only | |
2.6 Fluoxetine vs Maprotiline | 5 | 433 | Std. Mean Difference (IV, Random, 95% CI) | 0.04 [−0.15, 0.23] |
2.7 Fluoxetine vs Mianserin | 3 | 128 | Std. Mean Difference (IV, Random, 95% CI) | 0.43 [−0.38, 1.23] |
3 Failure to complete - Total | 6 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Subtotals only | |
3.1 Fluoxetine vs Maprotiline | 4 | 351 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.75 [0.93, 3.30] |
3.2 Fluoxetine vs Mianserin | 2 | 93 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.67 [0.27, 1.70] |
4 Failure to complete - Inefficacy | 4 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Subtotals only | |
4.1 Fluoxetine vs Maprotiline | 3 | 209 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 3.01 [0.73, 12.41] |
4.2 Fluoxetine vs Mianserin | 1 | 53 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 2.18 [0.40, 11.74] |
5 Failure to complete - Side Effects | 4 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Subtotals only | |
5.1 Fluoxetine vs Maprotiline | 3 | 209 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.54 [0.16, 1.83] |
5.2 Fluoxetine vs Mianserin | 1 | 53 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 1.04 [0.24, 4.64] |